The Clinical Times
The Front Page of Medicine

Latest medical news · page 132

The latest headlines across every section, pulled from official and open-access sources.

JAMA Network Open · Jun 30, 2026

Nasal CPAP vs IPPV in Preterm Infants With Respiratory Distress Syndrome

This randomized clinical trial examines whether nasal continuous positive airway pressure (CPAP) is noninferior to nasal intermittent positive pressure ventilation (IPPV) as primary respiratory support for reducing intubation within 72 hours in preterm infants with respiratory distress syndrome.

JAMA Network Open · Jun 30, 2026

SGLT2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders

This cohort study examines the association of initiated and sustained use of antidiabetic medications with risk for dementia, psychiatric emergency department use, or psychiatric hospitalization among older adults in the Veterans Affairs health care system.

JAMA Network Open · Jun 30, 2026

Barriers to Nutrition Security in the US

This cross-sectional study of US adults assesses associations among barriers to healthy eating, sociodemographic characteristics, and health conditions driven by poor diet.

MedCity News · Jun 29, 2026

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

June has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, the American Medical Association, CMS and R1 RCM named new executives. There were also layoffs at organizations including ADC Therapeutics, Equip and UPMC. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News .

MedCity News · Jun 29, 2026

4 Notable Health Tech Funding Announcements in June

Health tech companies made several major funding announcements in June. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in June appeared first on MedCity News .

FDA Drugs · Jun 29, 2026

Drug Trials Snapshots: PALSONIFY

PALSONIFY is a somatostatin receptor analog for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.

MedCity News · Jun 29, 2026

Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better

Ipsen is acquiring Kartos Therapeutics to get navtemadlin, which has reached Phase 3 testing in the blood cancer myelofibrosis. The Kartos oral small molecule takes a novel approach to restoring the function of p53, a tumor-suppressing protein. The post Ipsen’s $450M Deal Brings Drug That Could Make a Standard Blood Cancer Therapy Better appeared first on MedCity News .

FDA Drugs · Jun 29, 2026

Data Standards Program Strategic Plan and Board

The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program that will facilitate the efficient and effective review of regulatory submissions. This helps bring safe and effective products to market.

ACC (Cardiology) · Jun 29, 2026

Discontinuation of Oral Anticoagulation After AF Catheter Ablation (ALONE-AF): ALONE, but Not the Only One

The ALONE-AF (Anticoagulation One Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation) trial examined whether discontinuing oral anticoagulation (OAC) in patients with elevated stroke risk after catheter ablation of atrial fibrillation (AFCA) who remain free of atrial arrhythmias in the year after their indexed ablation leads to fewer adverse clinical outcomes.

FDA Drugs · Jun 29, 2026

Novel Drug Approvals for 2025

Innovative drugs often mean new treatment options for patients and advances in health care for the American public.

← NewerOlder →

Back to the live front page